LCID
Lucid Group, Inc.
LCID has the edge over OXM overall, supported by stronger fundamentals and stronger modeled upside.
OXM
Oxford Industries, Inc.
OXM has lower modeled downside risk, despite its lower overall score.
LCID Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
LCID's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
OXM Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Under pressure | |
| Healthy | |
| Healthy |
OXM's cash flow and balance sheet are currently healthy, and its revenue is stable, but its profitability is under pressure.
LCID PE Valuation
LCID has no meaningful PE right now: it lost money over the past year.
OXM PE Valuation
OXM has no meaningful PE right now: it lost money over the past year.
LCID Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect LCID's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
OXM Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Stable | |
| Growth | |
| Stable | |
| Limited | |
| High |
Analysts expect OXM's revenue to grow, with its earnings and profitability holding steady.
LCID Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$13.08 | -$2.57 |
| Q2 2026 | -$13.65 | -$2.35 |
| Q1 2026 | -$13.15 | -$1.25 |
| Q4 2025 | -$12.09 | +$0.41 |
| Q3 2025 | -$10.51 | +$2.49 |
| Q2 2025 | -$11.30 | +$0.40 |
| Q1 2025 | -$11.90 | +$0.40 |
| Q4 2024 | -$12.50 | +$1.10 |
LCID has the edge over OXM on earnings, with more consistent year-over-year improvement.
OXM Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.47 | — |
| Q3 2026 | -$0.43 | -112% |
| Q2 2026 | -$2.56 | -150% |
| Q1 2026 | -$1.86 | -132% |
| Q4 2025 | -$0.33 | -132% |
| Q3 2025 | $3.70 | +90% |
| Q2 2025 | $5.15 | +98% |
| Q1 2025 | $5.87 | +54% |
| Q4 2024 | $1.02 | -89% |
OXM has swung to a loss: it lost $0.43 per share over the past year, after a profit the year before.
LCID Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $350.3M | +4.1% |
| Q2 2026 | $405.3M | +56% |
| Q1 2026 | $282.5M | +20% |
| Q4 2025 | $522.7M | +123% |
| Q3 2025 | $336.6M | +68% |
| Q2 2025 | $259.4M | +29% |
| Q1 2025 | $235M | +36% |
| Q4 2024 | $234.5M | +49% |
LCID has the edge over OXM on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -245% | +35 points |
| Q2 2026 | -267% | +43 points |
| Q1 2026 | -350% | -56 points |
| Q4 2025 | -204% | +109 points |
| Q3 2025 | -280% | +105 points |
| Q2 2025 | -310% | +83 points |
| Q1 2025 | -294% | +128 points |
| Q4 2024 | -313% | +156 points |
LCID's operating margin was −245% last quarter, up 35 points from the same quarter a year ago, near the top of its range since 2020.
OXM Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $394.4M | -2.2% |
| Q2 2026 | $391.4M | -0.4% |
| Q1 2026 | $374.5M | -4.1% |
| Q4 2025 | $307.3M | -0.2% |
| Q3 2025 | $403.1M | -4% |
| Q2 2025 | $392.9M | -1.3% |
| Q1 2025 | $390.5M | -3.4% |
| Q4 2024 | $308M | -5.7% |
OXM's revenue grew through 2023 and has held roughly level since: $394M last quarter, down 2.2% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 17% | +11 points |
| Q2 2026 | 5.7% | -3.5 points |
| Q1 2026 | -2.1% | -7.3 points |
| Q4 2025 | -28% | -26 points |
| Q3 2025 | 6.3% | -6.2 points |
| Q2 2025 | 9.2% | -3.9 points |
| Q1 2025 | 5.2% | +25 points |
| Q4 2024 | -2% | -6.5 points |
OXM has the edge over LCID on profitability, with a higher operating margin.
LCID Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1B | -$84.2M |
| Q2 2026 | -$1.5B | -$463.2M |
| Q1 2026 | -$1.4B | -$849M |
| Q4 2025 | -$1.2B | -$417.1M |
| Q3 2025 | -$955.5M | -$333M |
| Q2 2025 | -$1B | -$271.6M |
| Q1 2025 | -$589.9M | +$125.1M |
| Q4 2024 | -$824.8M | -$77.6M |
LCID has burned cash in almost every quarter: −$5.2B over the past year, against −$3.4B the year before.
OXM Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $80.6M | +54% |
| Q2 2026 | -$14.9M | +$12.5M |
| Q1 2026 | $34.3M | -29% |
| Q4 2025 | -$47.9M | +$9M |
| Q3 2025 | $52.3M | +11% |
| Q2 2025 | -$27.4M | -230% |
| Q1 2025 | $48.5M | -12% |
| Q4 2024 | -$56.9M | -$50.7M |
OXM has the edge over LCID on cash generation, producing positive trailing cash flow while its opponent burns cash.
LCID Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.3% | +12.5M shares |
| 1 year | +26% | +82.4M shares |
| 3 years | +73% | +166M shares |
LCID has 395M diluted shares, up 26% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2020 | $2.2M |
| Q1 2020 | — |
OXM Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.5% | +73K shares |
| 1 year | +0.9% | +134K shares |
| 3 years | -5.6% | -901K shares |
| 5 years | -11% | -1.8M shares |
| Available history | -11% | -1.9M shares |
OXM has the edge over LCID on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | $14,000 |
| Q3 2025 | $4.7M |
| Q2 2025 | $50.5M |
| Q1 2025 | — |
| Q4 2024 | — |
OXM has spent almost nothing on buybacks in the past year.
LCID Net Leverage
LCID's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
OXM Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.0x | Healthy |
| Q2 2026 | 6.6x | High |
| Q1 2026 | 3.1x | Elevated |
| Q4 2025 | 2.1x | Moderate |
| Q3 2025 | 0.5x | Very low |
| Q2 2025 | 0.6x | Very low |
| Q1 2025 | 0.1x | Very low |
| Q4 2024 | 0.6x | Very low |
OXM's net debt is about a year of its operating earnings (EBITDA), up from less than a year a year ago.
LCID Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.9 | Neutral |
| Stochastic | 7.1 | Oversold |
LCID's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
OXM Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 40.4 | Neutral |
| Stochastic | 27.3 | Neutral |
OXM's weekly RSI is 40 (neutral) and its Stochastic is 27 (neutral).
LCID PE vs Consumer Cyclical Sector
LCID has no meaningful PE right now: it lost money over the past year.
OXM PE vs Consumer Cyclical Sector
| Metric | OXM | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 18x | — |
OXM has no meaningful PE right now: it lost money over the past year.
LCID Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.53 | 7.9% below |
| 20 week MA | $4.88 | 33% below |
| 50 week MA | $7.33 | 56% below |
| 100 week MA | $15.4 | 79% below |
| 200 week MA | $31.9 | 90% below |
LCID is in a downtrend: it's below all five of its weekly moving averages, and 90% below its 200-week average.
OXM Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $27.0 | 4.7% above |
| 20 week MA | $32.2 | 12% below |
| 50 week MA | $36.3 | 22% below |
| 100 week MA | $44.6 | 36% below |
| 200 week MA | $71.4 | 60% below |
OXM has the edge over LCID on trend strength, trading above more of its moving averages.
LCID Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $98.9 | $100.4 | +1.5% |
| 2021 | $100.4 | $376.4 | +275% |
| 2022 | $376.4 | $67.0 | -82% |
| 2023 | $67.0 | $42.1 | -37% |
| 2024 | $42.1 | $32.0 | -24% |
| 2025 | $32.0 | $11.4 | -64% |
| 2026 YTD | $11.4 | $3.25 | -72% |
LCID has finished four years in a row lower, and it's down 72% so far in 2026.
OXM Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $76.0 | $63.0 | -17% |
| 2021 | $63.0 | $96.0 | +52% |
| 2022 | $96.0 | $96.1 | +0.1% |
| 2023 | $96.1 | $100.0 | +4.1% |
| 2024 | $100.0 | $77.8 | -22% |
| 2025 | $77.8 | $34.3 | -56% |
| 2026 YTD | $34.3 | $28.3 | -17% |
OXM has the edge over LCID on returns for 2026, with the stronger performance.